Brief: Somnomed Ltd Says US FDA Cleared Rest Assure As Oral Device
07/10/2024 02:04
Oct 7 (Reuters) - Somnomed Ltd SOM.AX :
* US FDA CLEARED REST ASSURE AS ORAL DEVICE WITH IN-BUILT
COMPLIANCE MONITORING
Further company coverage: SOM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SomnoMed
See all newsAustralia's Somnomed jumps most in 7 months on strong half-year earnings
Brief: Somnomed® Increases Investment In Managed Care Infrastructure
Australia's Somnomed hits 32-month high on upbeat revenue growth
Brief: Somnomed Says Q1 FY26 Revenue Up 13.5% To A$28.7 Million
Brief: Somnomed Says FY EBITDA AUD 9.2 Million